Understanding the Role of Targets and Pathways in the Treatment of Chronic Lymphocytic Leukemia

Although this activity has expired, you may still view the supplement content. However, you will not be able to obtain CE credit.

This CME/CE/CPE accredited supplement is jointly provided by:

HSME NewlogoHSME Newlogo

JADPRO 5 Fig02

JADPRO 3 Fig02

Faculty

Christopher Arp, PharmD, Levine Cancer Institute—Carolinas HealthCare System, Department of Pharmacy

Kristan Augustin, PharmD, BCOP, Barnes-Jewish Hospital, Department of Pharmacy

Hani M. Babiker, MD, University of Arizona College of Medicine, Translational Genomics Research Institute, and University of Arizona Cancer Center

Andrew Garcia, PharmD, The University of Arizona Cancer Center

Ashley E. Glode, PharmD, BCOP, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences 

Amy Goodrich, MSN, CRNP, Johns Hopkins School of Medicine and The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Alyssa Hinchman, PharmD, The University of Arizona Cancer Center

Lindsay Hladnik, PharmD, BCOP, Washington University in Saint Louis School of Medicine, Department of Medicine

Nadia Khan, MD, Fox Chase Cancer Center

Sandra E. Kurtin, PhDc, ANP-C, AOCN®, The University of Arizona Cancer Center 

Ali McBride, PharmD, BCOP, The University of Arizona Cancer Center

Lisa Nodzon, PhD, ARNP, AOCNP®, Department of Malignant Hematology, Moffitt Cancer Center

Javier Pinilla-Ibarz, MD, PhD, Department of Malignant Hematology, Moffitt Cancer Center

Barbara Barnes Rogers, CRNP, MN, AOCN®, ANP-BC, Fox Chase Cancer Center

Nina Wagner-Johnston, MD, Johns Hopkins School of Medicine and The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

This activity is supported by unrestricted educational grants from
Gilead Sciences Inc. and Pharmacyclics LLC, an AbbVie Company and
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.


Editorial

A Letter From the Guest Editors

Sandra E. Kurtin, PhDc, ANP-C, AOCN®, and Ali McBride, PharmD, BCOP

Read More
Continuing Education

Chronic Lymphocytic Leukemia in 2018: What the Advanced Practitioner in Oncology Needs to Know

Sandra E. Kurtin, PhDc, ANP-C, AOCN®, and Ali McBride, PharmD, BCOP

Read More
Review Article

Scientific Advances in the Diagnosis and Risk Stratification of Chronic Lymphocytic Leukemia

Amy Goodrich, MSN, CRNP, and Nina Wagner-Johnston, MD

Read More
Review Article

Monoclonal Antibodies in Chronic Lymphocytic Leukemia

Lindsay Hladnik,(1) PharmD, BCOP, Kristan Augustin,(2) PharmD, BCOP, and Christopher Arp,(3) PharmD

Read More
Review Article

Small Molecules in Chronic Lymphocytic Leukemia: Novel Targets, New Challenges

Sandra E. Kurtin, PhDc, ANP-C, AOCN®, and Ali McBride, PharmD, BCOP

Read More
Review Article

Emerging Therapies in Chronic Lymphocytic Leukemia: Current Trials

Ashley E. Glode, PharmD, BCOP, and Hani M. Babiker, MD

Read More
Review Article

Risk-Adapted Treatment Strategies for Chronic Lymphocytic Leukemia

Lisa Nodzon, PhD, ARNP, AOCNP®, and Javier Pinilla-Ibarz, MD, PhD

Read More
Review Article

Supportive Care and Management of Treatment-Emergent Adverse Events in Chronic Lymphocytic Leukemia

Barbara Barnes Rogers, CRNP, MN, AOCN®, ANP-BC, and Nadia Khan, MD

Read More
Review Article

The Older Adult Living With Chronic Lymphocytic Leukemia: Implications for Oncology Providers, Patients, and Caregivers

Sandra E. Kurtin, PhDc, ANP-C, AOCN®

Read More
Appendix

Appendix

Compiled by Ali McBride, PharmD, BCOP, Andrew Garcia, PharmD, and Alyssa Hinchman, PharmD

Read More
Copyright © 2010-2023 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.